NATSUKO OKAMURA: Open Payments
NPI 1588933782 · WEST MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 16 payments from 12 companies in 2025. Trend: 2023 $1,038 · 2024 $399 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $364 |
| Medtronic, Inc. | 2 | $147 |
| Eisai Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Exact Sciences Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: BREZTRI, Leqembi, AIRSUPRA, CAPLYTA, UBRELVY, AVALUS, Veozah, INCEPTIV.
Industry payments across FL — which companies pay providers there.
